Pfizer–BioNTech COVID-19 vaksini (Azerbaijani Wikipedia)

Analysis of information sources in references of the Wikipedia article "Pfizer–BioNTech COVID-19 vaksini" in Azerbaijani language version.

refsWebsite

Global rank Azerbaijani rank

10web.archive.org

1^st place

1europa.eu

68^th place

167^th place

1wikipedia.org

low place

1fda.gov

447^th place

3,832^nd place

1cnbc.com

220^th place

1,377^th place

1nytimes.com

7^th place

55^th place

1doi.org

2^nd place

9^th place

1cdc.gov

218^th place

107^th place

1clinicaltrials.gov

5,225^th place

low place

1npr.org

92^nd place

718^th place

1statnews.com

8,771^st place

low place

1webmd.com

1,169^th place

2,928^th place

1go.com

48^th place

586^th place

1canada.ca

1,712^th place

7,691^st place

canada.ca

Public Health Agency of Canada (2 July 2021). Recommendations on the use of COVID-19 vaccines (PDF). Health Canada (Report). Archived (PDF) from the original on 23 June 2021. Retrieved 9 July 2021.

cdc.gov

"Pfizer–BioNTech COVID-19 Vaccine Standing Orders for Administering Vaccine to Persons 12 Years of Age and Older" Arxivləşdirilib 2021-03-02 at the Wayback Machine (PDF). U.S. Centers for Disease Control and Prevention (CDC). 28 September 2021. Retrieved 24 October 2021.

clinicaltrials.gov

"Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNT Vaccine Candidates Against COVID-19 in Healthy Individuals". ClinicalTrials.gov. 30 April 2020. Archived from the original on 11 October 2020. Retrieved 5 August 2021.

cnbc.com

Browne R (11 November 2020). "What you need to know about BioNTech – the European company behind Pfizer's Covid-19 vaccine". CNBC. Archived from the original on 4 March 2021. Retrieved 14 January 2021.

doi.org

Walsh EE, Frenck RW, Falsey AR, Kitchin N, Absalon J, Gurtman A, et al. (October 2020). "Safety and Immunogenicity of Two RNT-Based Covid-19 Vaccine Candidates". The New England JouRNTl of Medicine. 383 (25): 2439–50. doi:10.1056/NEJMoa2027906. PMC 7583697. PMID 33053279.

europa.eu

ema.europa.eu

"ComiRNTty EPAR"^{[ölü keçid]}. European Medicines Agency (EMA). Retrieved 24 October 2021.

fda.gov

"FDA Approves First COVID-19 Vaccine" (Press release). U.S. Food and Drug Administration (FDA). 23 August 2021. Archived from the original on 23 August 2021. Retrieved 23 August 2021.

go.com

abcnews.go.com

"Canada vaccine panel recommends 4 months between COVID doses". ABC News. 4 March 2021. Archived from the original on 26 July 2021. Retrieved 9 July 2021.

npr.org

Palca J (9 November 2020). "Pfizer says experimental COVID-19 vaccine is more than 90% effective". NPR.org. NPR. Archived from the original on 9 November 2020. Retrieved 9 November 2020.

nytimes.com

Thomas K, Gelles D, Zimmer C (9 November 2020). "Pfizer's early data shows vaccine is more than 90% effective". The New York Times. Archived from the original on 23 November 2020. Retrieved 9 November 2020.

statnews.com

Herper M (9 November 2020). "Covid-19 vaccine from Pfizer and BioNTech is strongly effective, early data from large trial indicate". Stat News. Archived from the original on 9 November 2020. Retrieved 9 November 2020.

web.archive.org

"FDA Approves First COVID-19 Vaccine" (Press release). U.S. Food and Drug Administration (FDA). 23 August 2021. Archived from the original on 23 August 2021. Retrieved 23 August 2021.
Browne R (11 November 2020). "What you need to know about BioNTech – the European company behind Pfizer's Covid-19 vaccine". CNBC. Archived from the original on 4 March 2021. Retrieved 14 January 2021.
Thomas K, Gelles D, Zimmer C (9 November 2020). "Pfizer's early data shows vaccine is more than 90% effective". The New York Times. Archived from the original on 23 November 2020. Retrieved 9 November 2020.
"Pfizer–BioNTech COVID-19 Vaccine Standing Orders for Administering Vaccine to Persons 12 Years of Age and Older" Arxivləşdirilib 2021-03-02 at the Wayback Machine (PDF). U.S. Centers for Disease Control and Prevention (CDC). 28 September 2021. Retrieved 24 October 2021.
"Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNT Vaccine Candidates Against COVID-19 in Healthy Individuals". ClinicalTrials.gov. 30 April 2020. Archived from the original on 11 October 2020. Retrieved 5 August 2021.
Palca J (9 November 2020). "Pfizer says experimental COVID-19 vaccine is more than 90% effective". NPR.org. NPR. Archived from the original on 9 November 2020. Retrieved 9 November 2020.
Herper M (9 November 2020). "Covid-19 vaccine from Pfizer and BioNTech is strongly effective, early data from large trial indicate". Stat News. Archived from the original on 9 November 2020. Retrieved 9 November 2020.
Ellis R. "CDC: Gap Between Vaccine Doses Could Be 6 Weeks". WebMD. Archived from the original on 4 may 2021. Retrieved 8 July 2021.
"Canada vaccine panel recommends 4 months between COVID doses". ABC News. 4 March 2021. Archived from the original on 26 July 2021. Retrieved 9 July 2021.
Public Health Agency of Canada (2 July 2021). Recommendations on the use of COVID-19 vaccines (PDF). Health Canada (Report). Archived (PDF) from the original on 23 June 2021. Retrieved 9 July 2021.

webmd.com

Ellis R. "CDC: Gap Between Vaccine Doses Could Be 6 Weeks". WebMD. Archived from the original on 4 may 2021. Retrieved 8 July 2021.

wikipedia.org

en.wikipedia.org

"ComiRNTty EPAR"^{[ölü keçid]}. European Medicines Agency (EMA). Retrieved 24 October 2021.